Back to top
Top
U.S. flag

An official website of the United States government

Proportion measure

Year CMS eCQM ID Measure Name
2024 CMS144v12 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 CMS144v13 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2026 CMS144v14 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 CMS145v11 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)
2024 CMS145v12 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF) less than or equal to 40%
2025 CMS145v13 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)
2026 CMS145v14 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)
2023 CMS146v11 Appropriate Testing for Pharyngitis
2024 CMS146v12 Appropriate Testing for Pharyngitis
2025 CMS146v13 Appropriate Testing for Pharyngitis
2026 CMS146v14 Appropriate Testing for Pharyngitis
2023 CMS147v12 Preventive Care and Screening: Influenza Immunization
2023 CMS149v11 Dementia: Cognitive Assessment
2024 CMS149v12 Dementia: Cognitive Assessment
2025 CMS149v13 Dementia: Cognitive Assessment
2026 CMS149v14 Dementia: Cognitive Assessment
2023 CMS153v11 Chlamydia Screening in Women
2024 CMS153v12 Chlamydia Screening in Women
2025 CMS153v13 Chlamydia Screening in Women
2026 CMS153v14 Chlamydia Screening in Women